文献
J-GLOBAL ID:201802291104562267
整理番号:18A0711273
切除不能肝細胞癌患者のファーストライン治療におけるレナバチニブ対ソラフェニブ:無作為化第3相非劣性試験【JST・京大機械翻訳】
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
著者 (22件):
Kudo Masatoshi
(Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan)
,
Finn Richard S
(Geffen School of Medicine at UCLA, Santa Monica, CA, USA)
,
Qin Shukui
(Nanjing Bayi Hospital, Nanjing, Jiangsu, China)
,
Han Kwang-Hyub
(Severance Hospital, Yonsei University, Seoul, South Korea)
,
Ikeda Kenji
(Toranomon Hospital, Tokyo, Japan)
,
Piscaglia Fabio
(University of Bologna, Bologna, Italy)
,
Baron Ari
(California Pacific Medical Center, San Francisco, CA, USA)
,
Park Joong-Won
(National Cancer Center Korea, Goyang-si, South Korea)
,
Han Guohong
(Xijing Hospital, Fourth Military Medical University, Xi’an, China)
,
Jassem Jacek
(Medical University of Gdansk, Gdansk, Poland)
,
Blanc Jean Frederic
(University of Bordeaux, Bordeaux, France)
,
Vogel Arndt
(Hannover Medical School, Hannover, Germany)
,
Komov Dmitry
(N N Blokhin Cancer Research Center, Moscow, Russia)
,
Evans T R Jeffry
(University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK)
,
Lopez Carlos
(Marques de Valdecilla University Hospital, Santander, Spain)
,
Dutcus Corina
(Eisai, Woodcliff Lake, NJ, USA)
,
Guo Matthew
(Eisai, Woodcliff Lake, NJ, USA)
,
Saito Kenichi
(Eisai, Woodcliff Lake, NJ, USA)
,
Kraljevic Silvija
(Eisai, Hatfield, UK)
,
Tamai Toshiyuki
(Eisai, Woodcliff Lake, NJ, USA)
,
Ren Min
(Eisai, Woodcliff Lake, NJ, USA)
,
Cheng Ann-Lii
(National Taiwan University Hospital, Taipei, Taiwan)
資料名:
Lancet
(Lancet)
巻:
391
号:
10126
ページ:
1163-1173
発行年:
2018年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)